New developments in the pharmacological modulation of wound healing after glaucoma filtration surgery

Current Opinion in Pharmacology

Volumn 13, Issue 1, 2013, Pages 65-71

  Lockwood, Alastair ^a,b   Brocchini, Stephen ^a,b   Khaw, Peng Tee ^a,c  

^a and University of Bristol   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; AMYLOID P COMPONENT; ANTIFIBROTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; BEVACIZUMAB; CYCLOSPORIN; DEXAMETHASONE; DOXYCYCLINE; FLUOROURACIL; MATRIX METALLOPROTEINASE; MICRORNA; NONSTEROID ANTIINFLAMMATORY AGENT; PRM 151; RANIBIZUMAB; RAPAMYCIN; RECOMBINANT PROTEIN; SARATIN; STEROID; TRANILAST; TRANSFORMING GROWTH FACTOR BETA; TRIAMCINOLONE ACETATE; UNCLASSIFIED DRUG; VASCULOTROPIN ANTIBODY; WOUND HEALING PROMOTING AGENT;

ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL PROLIFERATION; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG IMPLANT; ENZYME INHIBITION; EXTRACELLULAR MATRIX; EYE INJURY; FILTERING OPERATION; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; NEOVASCULAR GLAUCOMA; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OCULAR FIBROSIS; OPTIMAL DRUG DOSE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; SCAR; SUSTAINED DRUG RELEASE; TRABECULECTOMY; WOUND HEALING;

EID: 84871302161     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2012.10.008     Document Type: Review

References (64)

1. T.T. Wong, P.T. Khaw, T. Aung, P.J. Foster, H.M. Htoon, F.T. Oen, G. Gazzard, R. Husain, J.G. Devereux, and D. Minassian The Singapore 5-fluorouracil trabeculectomy study: effects on intraocular pressure control and disease progression at 3 years Ophthalmology 116 2009 175 184
2. J.E. Park, and A. Barbul Understanding the role of immune regulation in wound healing Am J Surg 187 2004 11S 16S
3. P.T. Khaw, M. Chiang, P. Shah, F. Sii, A. Lockwood, and A. Khalili Enhanced trabeculectomy: the Moorfields Safer Surgery System Dev Ophthalmol 50 2012 1 28
4. A.R. Kent, H.B. Dubiner, R. Whitaker, T.K. Mundorf, J.A. Stewart, E.A. Cate, and W.C. Stewart The efficacy and safety of diclofenac 0.1% versus prednisolone acetate 1% following trabeculectomy with adjunctive mitomycin-C Ophthalmic Surg Lasers 29 1998 562 569
5. ® or mitomycin-C Mol Vis 18 2012 714 719
6. C.C. Tham, F.C. Li, D.Y. Leung, Y.Y. Kwong, D.W. Yick, C.C. Chi, and D.S. Lam Intrableb triamcinolone acetonide injection after bleb-forming filtration surgery (trabeculectomy, phacotrabeculectomy, and trabeculectomy revision by needling): a pilot study Eye (Lond) 20 2006 1484 1486
7. M. Löbler, K. Sternberg, O. Stachs, R. Allemann, N. Grabow, A. Roock, C.F. Kreiner, D. Streufert, A.T. Neffe, and B.D. Hanh Polymers and drugs suitable for the development of a drug delivery drainage system in glaucoma surgery J Biomed Mater Res Part B Appl Biomater 97 2011 388 395
8. K. Yuki, D. Shiba, I. Kimura, Y. Ohtake, and K. Tsubota Trabeculectomy with or without intraoperative sub-tenon injection of triamcinolone acetonide in treating secondary glaucoma Am J Ophthalmol 147 2009 1055 1060.e2
9. S. Shaunak, S. Thomas, E. Gianasi, A. Godwin, E. Jones, I. Teo, K. Mireskandari, P. Luthert, R. Duncan, and S. Patterson Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation Nat Biotechnol 22 2004 977 984
10. R. Gaudana, J. Jwala, S.H. Boddu, and A.K. Mitra Recent perspectives in ocular drug delivery Pharm Res 26 2009 1197 1216
11. A.J. Flach Topical nonsteroidal antiinflammatory drugs in ophthalmology Int Ophthalmol Clin 42 2002 1 11
12. A. Kim, and W.J. Stark Are topical NSAIDs needed for routine cataract surgery? Am J Ophthalmol 146 2008 483 485
13. D. Yuen, Y. Buys, Y.P. Jin, T. Alasbali, M. Smith, and G.E. Trope Corticosteroids versus NSAIDs on intraocular pressure and the hypertensive phase after Ahmed glaucoma valve surgery J Glaucoma 20 2011 439 444
14. K.H. Park, D.M. Kim, and D.H. Youn Topical cyclosporine and glaucoma drainage implant surgery in rabbits Ophthalmic Surg Lasers 27 1996 452 458
15. F.A. Lattanzio, E.R. Crouch, P.V. Mitrev, P.B. Williams, and R.C. Allen Cyclosporin as an adjunct to glaucoma filtration surgery J Glaucoma 14 2005 441 447
16. G. Fakhraie, J.F. Lopes, G.L. Spaeth, J. Almodin, P. Ichhpujani, and M.R. Moster Effects of postoperative cyclosporine ophthalmic emulsion 0.05% (Restasis) following glaucoma surgery Clin Exp Ophthalmol 37 2009 842 848
17. Z.C. Yan, Y.J. Bai, Z. Tian, H.Y. Hu, X.H. You, J.X. Lin, S.R. Liu, Y.H. Zhuo, and R.J. Luo Anti-proliferation effects of Sirolimus sustained delivery film in rabbit glaucoma filtration surgery Mol Vis 17 2011 2495 2506
18. Z.L. Lukowski, J. Min, A.R. Beattie, and C.A. Meyers Prevention of ocular scarring after glaucoma filtering surgery using the monoclonal antibody LT1009 (Sonepcizumab) in a rabbit model J Glaucoma 2011 10.1097/IJG.0b013e31822e8c83
19. K.K. Hoyer, H. Dooms, L. Barron, and A.K. Abbas Interleukin-2 in the development and control of inflammatory disease Immunol Rev 226 2008 19 28
20. J. Koreth, K. Matsuoka, H.T. Kim, S.M. McDonough, B. Bindra, E.P. Alyea, P. Armand, C. Cutler, V.T. Ho, and N.S. Treister Interleukin-2 and regulatory T cells in graft-versus-host disease N Engl J Med 365 2011 2055 2066
21. D. Horbelt, A. Denkis, and P. Knaus A portrait of transforming growth factor β superfamily signalling: background matters Int J Biochem Cell Biol 44 2012 469 474
22. T. Stahnke, M. Löbler, C. Kastner, O. Stachs, A. Wree, K. Sternberg, K.P. Schmitz, and R. Guthoff Different fibroblast subpopulations of the eye: a therapeutic target to prevent postoperative fibrosis in glaucoma therapy Exp Eye Res 100 2012 88 97
23. Y. Takai, M. Tanito, and A. Ohira Multiplex cytokine analysis of aqueous humor in eyes with primary open-angle glaucoma, exfoliation glaucoma, and cataract Invest Ophthalmol Vis Sci 53 2012 241 247
24. T. Tovar-Vidales, A.F. Clark, and R.J. Wordinger Transforming growth factor-beta2 utilizes the canonical Smad-signaling pathway to regulate tissue transglutaminase expression in human trabecular meshwork cells Exp Eye Res 93 2011 442 451
25. T. Meyer-Ter-Vehn, F. Grehn, and G. Schlunck Localization of TGF-beta type II receptor and ED-A fibronectin in normal conjunctiva and failed filtering blebs Mol Vis 14 2008 136 141
26. M. Cordeiro, A. Mead, R. Ali, R. Alexander, S. Murray, C. Chen, C. York-Defalco, N. Dean, G. Schultz, and P. Khaw Novel antisense oligonucleotides targeting TGF-β inhibit in vivo scarring and improve surgical outcome Gene Ther 10 2003 59 71
27. M.F. Cordeiro, J. Gay, and P.T. Khaw Human anti-transforming growth factor-beta2 antibody: a new glaucoma anti-scarring agent Invest Ophthalmol Vis Sci 40 1999 2225 2234
28. D. Siriwardena, P.T. Khaw, A.J. King, M.L. Donaldson, B.M. Overton, C. Migdal, and M.F. Cordeiro Human antitransforming growth factor beta(2) monoclonal antibody - a new modulator of wound healing in trabeculectomy: a randomized placebo controlled clinical study Ophthalmology 109 2002 427 431
29. Group CAT-TS, P.T. Khaw, F. Grehn, G. Holló, B. Overton, R. Wilson, R. Vogel, and Z. Smith A phase III study of subconjunctival human anti-transforming growth factor beta(2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy Ophthalmology 114 2007 1822 1830
30. A.L. Mead, T.T. Wong, M.F. Cordeiro, I.K. Anderson, and P.T. Khaw Evaluation of anti-TGF-beta2 antibody as a new postoperative anti-scarring agent in glaucoma surgery Invest Ophthalmol Vis Sci 44 2003 3394 3401
31. Z. Zi, D.A. Chapnick, and X. Liu Dynamics of TGF-β/Smad signaling FEBS Lett 586 2012 1921 1928
32. Y. Xiao, K. Liu, J. Shen, G. Xu, and W. Ye SB-431542 inhibition of scar formation after filtration surgery and its potential mechanism Invest Ophthalmol Vis Sci 50 2008 1698 1706
33. J. Sapitro, J.J. Dunmire, S.E. Scott, V. Sutariya, W.J. Geldenhuys, M. Hewit, B.Y. Yue, and H. Nakamura Suppression of transforming growth factor-β effects in rabbit subconjunctival fibroblasts by activin receptor-like kinase 5 inhibitor Mol Vis 16 2010 1880 1892
34. M. Spitzer, M. Sat, C. Schramm, S. Schnichels, M. Schultheiss, E. Yoeruek, D. Dzhelebov, and P. Szurman Biocompatibility and antifibrotic effect of UV-cross-linked hyaluronate as a release-system for tranilast after trabeculectomy in a rabbit model - a pilot study Curr Eye Res 37 2012 463 470
35. M. Jinek, and J.A. Doudna A three-dimensional view of the molecular machinery of RNA interference Nature 457 2009 405 412
36. N. Li, J. Cui, X. Duan, H. Chen, and F. Fan Suppression of type I collagen expression by miR-29b via PI3K, Akt, and Sp1 pathway in human Tenon's fibroblasts Invest Ophthalmol Vis Sci 53 2012 1670 1678
37. R. Abe, S.C. Donnelly, T. Peng, R. Bucala, and C.N. Metz Peripheral blood fibrocytes: differentiation pathway and migration to wound sites J Immunol 166 2001 7556 7562
38. D. Pilling, C.D. Buckley, M. Salmon, and R.H. Gomer Inhibition of fibrocyte differentiation by serum amyloid P J Immunol 171 2003 5537 5546
39. D. Pilling, D. Roife, M. Wang, S.D. Ronkainen, J.R. Crawford, E.L. Travis, and R.H. Gomer Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P J Immunol 179 2007 4035 4044
40. M.R. Santhiago, V. Singh, F.L. Barbosa, V. Agrawal, and S.E. Wilson Monocyte development inhibitor PRM-151 decreases corneal myofibroblast generation in rabbits Exp Eye Res 93 2011 786 789
41. P. Carmeliet, and R. Jain Molecular mechanisms and clinical applications of angiogenesis Nature 473 2011 298 307
42. T.A. Wilgus, A.M. Ferreira, T.M. Oberyszyn, V.K. Bergdall, and L.A. Dipietro Regulation of scar formation by vascular endothelial growth factor Lab Invest 88 2008 579 590
43. D. Beddy, R.W.G. Watson, J.M. Fitzpatrick, and P.R. O'Connell Increased vascular endothelial growth factor production in fibroblasts isolated from strictures in patients with Crohn's disease Br J Surg 91 2004 72 77
44. Z. Li, T. Van Bergen, S. Van de Veire, I. Van de Vel, H. Moreau, M. Dewerchin, P.C. Maudgal, T. Zeyen, W. Spileers, L. Moons, and I. Stalmans Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery Invest Ophthalmol Vis Sci 50 2009 5217 5225
45. F. Memarzadeh, R. Varma, L. Lin, J.G. Parikh, L. Dustin, A. Alcaraz, and D. Eliott Postoperative use of bevacizumab as an antifibrotic agent in glaucoma filtration surgery in the rabbit Invest Ophthalmol Vis Sci 50 2009 3233 3237
46. A. How, J.L.L. Chua, A. Charlton, R. Su, M. Lim, R.S. Kumar, J.G. Crowston, and T.T. Wong Combined treatment with bevacizumab and 5-fluorouracil attenuates the postoperative scarring response after experimental glaucoma filtration surgery Invest Ophthalmol Vis Sci 51 2010 928 932
47. M.Y. Kahook, J.S. Schuman, and R.J. Noecker Needle bleb revision of encapsulated filtering bleb with bevacizumab Ophthalmic Surg Lasers Imaging 37 2006 148 150
48. D.S. Grewal, R. Jain, H. Kumar, and S.P. Grewal Evaluation of subconjunctival bevacizumab as an adjunct to trabeculectomy a pilot study Ophthalmology 115 2008 2141 2145.e2
49. N. Nilforushan, M. Yadgari, S. Kish, and N. Nassiri Subconjunctival bevacizumab versus mitomycin C adjunctive to trabeculectomy Am J Ophthalmol 153 2012 352 357
50. J. Jurkowska-Dudzińska, E. Kosior-Jarecka, and T. Żarnowski Comparison of the use of 5-fluorouracil and bevacizumab in primary trabeculectomy: results at 1 year Clin Exp Ophthalmol 40 2012 135 142
51. H. Nomoto, F. Shiraga, N. Kuno, E. Kimura, S. Fujii, K. Shinomiya, A. Nugent, K. Hirooka, and T. Baba Pharmacokinetics of bevacizumab after topical, subconjunctival, and intravitreal administration in rabbits Invest Ophthalmol Vis Sci 50 2009 4807 4813
52. F. Bochmann, C. Kaufmann, C.N. Becht, I. Guber, M. Kaiser, L.M. Bachmann, and M.A. Thiel ISRCTN12125882-influence of topical anti-VEGF (Ranibizumab) on the outcome of filtration surgery for glaucoma-study protocol BMC Ophthalmol 11 2011 1
53. K.S. Cornish, S. Ramamurthi, S. Saidkasimova, and K. Ramaesh Intravitreal bevacizumab and augmented trabeculectomy for neovascular glaucoma in young diabetic patients Eye (Lond) 23 2009 979 981
54. J. Min, Z.L. Lukowski, M.A. Levine, C.A. Meyers, A.R. Beattie, G.S. Schultz, D.A. Samuelson, and M.B. Sherwood Prevention of ocular scarring post glaucoma filtration surgery using the inflammatory cell and platelet binding modulator saratin in a rabbit model PLoS ONE 2012 7 10.1371/journal.pone.0035627
55. M. Gooz ADAM-17: the enzyme that does it all Crit Rev Biochem Mol Biol 45 2010 146 169
56. Y. Wang, Z. Tang, R. Xue, G.K. Singh, Y. Lv, K. Shi, K. Cai, L. Deng, and L. Yang TGF-β1 promoted MMP-2 mediated wound healing of anterior cruciate ligament fibroblasts through NF-κB Connect Tissue Res 52 2011 218 225
57. P. McCluskey, A. Molteno, D. Wakefield, and N.D. Girolamo Otago Glaucoma Surgery Outcome Study: the pattern of expression of MMPs and TIMPs in bleb capsules surrounding Molteno implants Invest Ophthalmol Vis Sci 50 2009 2161 2164
58. J.T. Daniels, A.D. Cambrey, N.L. Occleston, Q. Garrett, R.W. Tarnuzzer, G.S. Schultz, and P.T. Khaw Matrix metalloproteinase inhibition modulates fibroblast-mediated matrix contraction and collagen production in vitro Invest Ophthalmol Vis Sci 44 2003 1104 1110
59. T.T. Wong, A.L. Mead, and P.T. Khaw Prolonged antiscarring effects of ilomastat and MMC after experimental glaucoma filtration surgery Invest Ophthalmol Vis Sci 46 2005 2018 2022
60. B. Martin-Martin, V. Tovell, A.H. Dahlmann-Noor, P.T. Khaw, and M. Bailly The effect of MMP inhibitor GM6001 on early fibroblast-mediated collagen matrix contraction is correlated to a decrease in cell protrusive activity Eur J Cell Biol 90 2011 26 36
61. V.E. Tovell, C.Y. Chau, P.T. Khaw, and M. Bailly Rac1 inhibition prevents tissue contraction and MMP mediated matrix remodeling in the conjunctiva Invest Ophthalmol Vis Sci 53 2012 4682 4691
62. G. Parkinson, S. Gaisford, Q. Ru, A. Lockwood, A. Khalili, R. Sheridan, P.T. Khaw, S. Brocchini, and H.M. Fadda Characterisation of Ilomastat for prolonged ocular drug release AAPS PharmSciTch 2012 10.1208/s12249-012-9832-1
63. E. Sen, M. Balikoglu-Yilmaz, S. Bozdag-Pehlivan, N. Sungu, F.N. Aksakal, A. Altinok, T. Tuna, N. Unlu, H. Ustun, G. Koklu, and F. Öztürk Effect of doxycycline on postoperative scarring after trabeculectomy in an experimental rabbit model J Ocul Pharmacol Ther 26 2010 399 406
64. G. Heatley, J. Kiland, B. Faha, J. Seeman, C.L. Schlamp, D.G. Dawson, J. Gleiser, D. Maneval, P.L. Kaufman, and R.W. Nickells Gene therapy using p21WAF-1/Cip-1 to modulate wound healing after glaucoma trabeculectomy surgery in a primate model of ocular hypertension Gene Ther 11 2004 949 955